Lilly to sell New Jersey facility as it nears picks for new US sitesnews2025-08-01T17:30:48+00:00August 1st, 2025|Endpoints News|
Moderna gets UK appeals court win in Covid patent battle with Pfizer, BioNTechnews2025-08-01T17:18:46+00:00August 1st, 2025|Endpoints News|
Analysts wary of Moderna’s CMV fate after new endpoints addednews2025-08-01T15:14:55+00:00August 1st, 2025|Endpoints News|
Regeneron gets another CRL, predicts delayed August PDUFA for Eylea HDnews2025-08-01T11:37:56+00:00August 1st, 2025|Endpoints News|
Bayer says pharma sales exceed expectations, bumps full-year guidancenews2025-08-01T10:47:58+00:00August 1st, 2025|Endpoints News|
FDA approves Lenz’s eye drop for presbyopia, a tricky market for other biopharmasnews2025-07-31T20:56:20+00:00July 31st, 2025|Endpoints News|
Merck will shed 6,000 jobs as it eyes $3B in cost cutsnews2025-07-31T20:04:24+00:00July 31st, 2025|Endpoints News|
HRSA unveils pilot program for 340B rebate modelnews2025-07-31T19:49:42+00:00July 31st, 2025|Endpoints News|
FDA chief wants more harmony between CBER and CDERnews2025-07-31T19:48:19+00:00July 31st, 2025|Endpoints News|
Trump demands pharma CEOs implement ‘most favored nation’ pricing within 60 daysnews2025-07-31T18:19:26+00:00July 31st, 2025|Endpoints News|
